First study to evaluate HER2DX in a randomized trial focused exclusively on older individuals (aged 70-80 years). HER2DX independently predicts long-term survival outcomes in patients treated ...
HER2DX is a prognostic, predictive assay based on clinical and genomic data. The test integrates clinical information (i.e.
At-home gut microbiome tests are trending, selling insights to the curious, empowerment to the chronically ill and a claimed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback